Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels
Ceramides are a type of sphingolipid (SL) that have been shown to play a role in several metabolic disorders. Here, the authors investigate the effect of SL-production by gut Bacteroides on host SL homeostasis and show that microbiome-derived SLs enter host circulation and alter ceramide production.
Main Authors: | Elizabeth L. Johnson, Stacey L. Heaver, Jillian L. Waters, Benjamin I. Kim, Alexis Bretin, Andrew L. Goodman, Andrew T. Gewirtz, Tilla S. Worgall, Ruth E. Ley |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-16274-w |
Similar Items
-
The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health
by: Jillian L. Waters, et al.
Published: (2019-10-01) -
Structural determinants of sphingolipid recognition by commercially available anti-ceramide antibodies
by: L.Ashley Cowart, et al.
Published: (2002-12-01) -
Optical manipulation of sphingolipid biosynthesis using photoswitchable ceramides
by: Matthijs Kol, et al.
Published: (2019-02-01) -
Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?
by: Michael Mah, et al.
Published: (2021-07-01) -
Dietary long-chain omega 3 fatty acids modify sphingolipid metabolism to facilitate airway hyperreactivity
by: Andrea Heras, et al.
Published: (2022-11-01)